NCT01566149View on ClinicalTrials.gov

Study of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in Adolescents & Adults With Persistent Asthma (P08212)

PHASE3CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Asthma
Interventions
DRUG

Mometasone Furoate/Formoterol Fumarate (MF/F) 100/5 mcg MDI

Two oral inhalations per dose

DRUG

Mometasone Furoate/Formoterol Fumarate (MF/F) 200/5 mcg MDI

Two oral inhalations per dose

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT01566149 - Study of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in Adolescents & Adults With Persistent Asthma (P08212) | Biotech Hunter | Biotech Hunter